ElMindA, an Israeli company which has developed a helmet like device which covers the head and performs non-invasive brain scans has received approval from the FDA for its BNA Analysis Systems.
BNA, brain network activity, combines non-invasive, multi-channel EEG technology with sophisticated signal processing and analysis algorithms to measure patterns of brain networks activated during specific brain processes. The company says that it delivers both quantitative and qualitative insights into brain functionality.
Jeffrey S. Kutcher, M.D., associate professor of neurology, University of Michigan Medical School, said, “BNA allows physicians to assess brain health using objective neurological measurements. This will allow those of us caring for patients the ability to more clearly differentiate a healthy brain from one affected by disease or injury.”
ElMindA has already established a growing database of brain activity from both healthy subjects and patients with brain-related disorders. The database currently includes more than 7, 000 BNA datasets, which provide a robust, clinically supported foundation to potentially help identify and manage neurological disorders such as ADHD or pain, and brain injuries such as concussion.
Ronen Gadot, ElMindA’s CEO and co-founder, told Globes, “Other imaging systems, like MRI or CT, show us how the brain is built, which is like reading a map, whereas we show what the brain activity is in real time, which is like a traffic report.”
He also stated in a press release, “Greater understanding of how our brain processes information, how it gets its job done, ultimately holds the potential to improve brain health and disease management over a person’s lifetime. BNA adds an objective layer of information to clinical symptom assessments and neurocognitive tests, providing clinicians with a comprehensive view of brain health.”
Founded in 2006 and based on Ben Gurion University Professor Amir Geva’s technology, ElMindA declares its vison to revolutionize the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice, opening a new window into the brain’s functionality, and enabling well-informed clinical decision making.
The company uses a data-driven approach to transform algorithmic science and neuroscience expertise into routine clinical practice.
Ronen Gadot has an MBA from INSEAD and a BSc in Industrial Engineering from the University of New Haven. Professor Amir Geva, the company’s CTO, is the of the Biomedical Signal Processing & Pattern Recognition Laboratory, Electrical & Computer Engineering, at the Ben Gurion University. An accomplished scientist and entrepreneur, with years of brain and EEG research and experience.